MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Tremor characteristics differentially respond to levodopa and subthalamic nucleus deep brain stimulation in Parkinson’s disease

    T. Wirth, F. Ferreira, N. Vijiaratnam, C. Girges, A. Pakzad, A. Roquemaurel, O. Sinani, J. Hyam, M. Hariz, L. Zrinzo, H. Akram, P. Limousin, T. Foltynie (Strasbourg, France)

    Objective: To identify factors predictive of responsiveness of tremor to levodopa and STN-DBS. Background: Tremor in Parkinson’s disease (PD) is phenotypically variable and has an…
  • 2023 International Congress

    A cross-sectional study of telemedicine use during the COVID-19 pandemic in people with Parkinson’s disease

    A. Patel, R. Schuldt, D. Boudreau, N. Win, B. Cobb, M. Mcginley (South San Francisco, USA)

    Objective: To evaluate telemedicine (TM) use and access patterns during the COVID-19 pandemic in people with Parkinson’s disease (pwPD). Background: pwPD may experience difficulty accessing…
  • 2023 International Congress

    The Effects of Consecutive and Integrated Postural-Cognitive Training on Dual-task Walking in Parkinson’s Disease with Mild Cognitive Impairment: EEG Relative Power and Clinical Implication

    YA. Chen, CY. Huang, RM. Wu, CL. Chang (Taipei, Taiwan)

    Objective: The purpose of this study was to compare the effects of consecutive and integrated postural-cognitive training on dual-task walking performance and its related cortical…
  • 2023 International Congress

    Levodopa-entacapone-carbidopa-infusion treatment in Parkinson’s disease: A six-month follow-up study

    V. Viljaharju, T. Mertsalmi, KAM. Pauls, M. Koivu, J. Eerola-Rautio, M. Udd, E. Pekkonen (Helsinki, Finland)

    Objective: Objectives of this study were to evaluate changes in medication, adverse events and early discontinuations of levodopa-entacapone-carbidopa-intestinal-gel (LECIG) treatment in advanced Parkinson’s disease (PD).…
  • 2023 International Congress

    Automatic cluster analysis using semantic relatedness for verbal fluency tasks in Parkinson’s disease

    T. Hähnel, T. Feige, J. Kunze, A. Epler, A. Frank, J. Bendig, N. Schnalke, M. Wolz, P. Themann, B. Falkenburger (Dresden, Germany)

    Objective: The aim of this work was to develop and validate a method for automated identification of semantically related clusters for verbal fluency tasks (VFT)…
  • 2023 International Congress

    Signs of Respiratory Dysfunction across Parkinson’s Disease Spectrum

    J. Janssen Daalen, P. Ainslie, H. van Hees, M. Meinders, D. Thijsse, B. Bloem (Nijmegen, Netherlands)

    Objective: The aim of the study is to investigate signs of respiratory dysfunction across the Parkinson’s disease spectrum. Background: Respiratory dysfunction in Parkinson’s disease (PD)…
  • 2023 International Congress

    Very high frequency of early-onset Parkinson’s disease with homozygous PRKN exon 3 deletion amongst indigenous populations in Sabah, Malaysia

    YW. Tay, JCE. Ooi, SY. Lim, YK. Chia, A. Sukri, TS. Toh, JL. Lim, AH. Tan, A. Ahmad-Annuar (Kuala Lumpur, Malaysia)

    Objective: We aimed to investigate the frequency of EOPD and PRKN mutations in our diverse Malaysian indigenous populations, who are extremely under-represented in PD genetics…
  • 2023 International Congress

    Local field potential changes by the patient’s conditions; 1-year follow-up of adaptive deep brain stimulation in the real world.

    H. Kamo, G. Oyama, M. Ito, H. Iwamuro, A. Umemura, N. Hattori (Tokyo, Japan)

    Objective: To evaluate changes of local field potential (LFP) in patients with Parkinson’s disease (PD) by patient conditions and overtime for one year after surgery…
  • 2023 International Congress

    The N6-Methyladenosine mRNA Methylase METTL14 Regulates TLR4-mediated intestinal dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, ZZ. Lu, L. Wei, LL. Wu, F. Yu (Guangzhou, China)

    Objective: The aim of this study is to explore the function and mechanism of RNA m6A modification in gut-derived inflammation of Parkinson's disease (PD). Background:…
  • 2023 International Congress

    Validating wearable sensors as an assessment tool for Parkinson’s Disease

    K. Silis, N. Kieran, N. Shawki, S. Madarshahian, M. Serruya, T. Liang (Philadelphia, USA)

    Objective: The objective of our pilot study was to assess the feasibility of using a portable accelerometer system to accurately identify motor findings in patients…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley